Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Adimmune Corporation (4142) Financial Statements

Adimmune Corporation Financial Overview

Adimmune Corporation's market cap is currently NT$7.22B. The company's EPS TTM is NT$-0.34; its P/E ratio is -48.68; and it has a dividend yield of 0.94%. Adimmune Corporation has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 1.40BNT$ 1.56BNT$ 1.79BNT$ 2.25BNT$ 1.64B
Gross ProfitNT$ 288.49MNT$ 448.06MNT$ 410.94MNT$ 891.08MNT$ 464.14M
Operating IncomeNT$ -359.55MNT$ -299.09MNT$ -722.75MNT$ 98.55MNT$ -54.09M
EBITDANT$ -144.69MNT$ -84.30MNT$ -512.43MNT$ 438.12MNT$ 254.89M
Net IncomeNT$ -239.89MNT$ -242.75MNT$ -639.89MNT$ 290.98MNT$ 43.07M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 2.24BNT$ 2.47BNT$ 2.49BNT$ 2.97BNT$ 2.89B
Total AssetsNT$ 8.19BNT$ 8.48BNT$ 9.48BNT$ 9.15BNT$ 8.01B
Total DebtNT$ 2.83BNT$ 2.60BNT$ 3.14BNT$ 2.26BNT$ 1.32B
Net DebtNT$ 644.08MNT$ 252.12MNT$ 685.13MNT$ -594.50MNT$ -1.33B
Total LiabilitiesNT$ 3.14BNT$ 2.92BNT$ 3.71BNT$ 2.60BNT$ 1.58B
Stockholders' EquityNT$ 4.94BNT$ 5.23BNT$ 5.47BNT$ 6.12BNT$ 6.15B
Cash Flow
Free Cash FlowNT$ -242.18MNT$ 513.26MNT$ -1.11BNT$ -711.59MNT$ -1.33B
Operating Cash FlowNT$ -5.45MNT$ 668.48MNT$ -892.35MNT$ -291.96MNT$ -480.52M
Investing Cash FlowNT$ -198.98MNT$ -310.90MNT$ -366.56MNT$ -322.07MNT$ -728.84M
Financing Cash FlowNT$ 56.19MNT$ -478.80MNT$ 859.30MNT$ 823.19MNT$ -222.89M

Currency in TWD

Adimmune Corporation Earnings and Revenue History

-1.5B01.5B3B-160 %-80 %0 %80 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Adimmune Corporation Liabilities to Assets

04B8B12B0 %25 %50 %75 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Adimmune Corporation Cash Flow

-2B-1B01B2B3B201720182019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Adimmune Corporation Forecast EPS vs Actual EPS

-0.7-0.5-0.200.30.50.8Q3 25Q4 25Q1 26Q2 26Q3 26EPS EstimateBeatMiss
Earnings >